D. Radley

发表

The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

E. Antman, E. Braunwald, C. McCabe, 2000, JAMA.

Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction.

E. Antman, M. Cohen, A. Turpie, 2000, The American journal of cardiology.

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.

H. Jessen, A. Giuliano, J. Palefsky, 2011, The New England journal of medicine.

Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events.

R. Califf, M. Cohen, A. Langer, 2000, Journal of the American College of Cardiology.

An Open-Label, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine Given Concomitantly With Diphtheria, Tetanus, Pertussis, and Poliomyelitis Vaccine in Healthy Adolescents 11 to 17 Years of Age

P. van Damme, T. Vesikari, S. Vuocolo, 2009, The Pediatric infectious disease journal.

Pregnancy and Infant Outcomes in the Clinical Trials of a Human Papillomavirus Type 6/11/16/18 Vaccine: A Combined Analysis of Five Randomized Controlled Trials

S. Garland, K. Ault, A. Saah, 2009, Obstetrics and gynecology.

Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes.

E. Antman, S. Murphy, Marc Cohen, 2002, American heart journal.

Enoxaparin in Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction: Treatment Benefits in Prespecified Subgroups

E. Antman, E. Gurfinkel, Marc Cohen, 2001, Journal of Thrombosis and Thrombolysis.

Safety and Immunogenicity of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine in HIV-Infected Children 7 to 12 Years Old

A. Moscicki, A. Saah, M. Levin, 2010, Journal of acquired immune deficiency syndromes.

Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine.

A. Giuliano, L. Villa, E. Lazcano-Ponce, 2007, The Journal of infectious diseases.

Persistent infection with human papillomavirus 16 or 18 is strongly linked with high-grade cervical disease

M. Stanley, A. Saah, D. Radley, 2016, Human vaccines & immunotherapeutics.

A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine

E. Walsh, A. Falsey, P. Dormitzer, 2021, The Journal of infectious diseases.

MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies

J. Absalon, John L. Perez, R. O'neill, 2020, Infectious Diseases and Therapy.

A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults

J. Absalon, John L. Perez, K. Jansen, 2017, The New England journal of medicine.

Prior aspirin use in unstable angina predisposes to higher risk: the aspirin paradox.

M. Cohen, G. Lancaster, D. Radley, 2001, International journal of cardiology.

Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults

A. Bett, B. Coller, D. Radley, 2019, Human vaccines & immunotherapeutics.

Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.

S. Halperin, F. Diaz-Mitoma, D. Radley, 2009, Vaccine.

Safety and Immunogenicity of Two Formulations of a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae b Conjugate-Hepatitis B Vaccine in 15 to 18 Month-Old Children

J. Langley, S. Halperin, D. Radley, 2005, Human vaccines.

Safety, tolerability and immunogenicity of low dose Haemophilus influenzae type b conjugated to the outer membrane protein complex of Neisseria meningitidis group B.

J. Donnelly, S. Frey, D. Radley, 2002, The Pediatric infectious disease journal.

Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes

M. Baudin, B. Soubeyrand, J. Grabenstein, 2016, Human vaccines & immunotherapeutics.

Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis.

E. Antman, E. Braunwald, C. McCabe, 1999, Circulation.

Randomized Trial of Low Molecular Weight Heparin (Enoxaparin) Versus Unfractionated Heparin for Unstable Coronary Artery Disease One-Year Results of the ESSENCE Study Enoxaparin in Non–Q

R. Califf, M. Cohen, A. Langer, 2016 .

Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18.

M. Pawlita, A. Saah, P. Sehr, 2014, Vaccine.

From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine

J. Absalon, John L. Perez, K. Jansen, 2018, Expert review of vaccines.

Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy.

P. Dormitzer, A. Gurtman, K. Swanson, 2022, The New England journal of medicine.

HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.

H. Jessen, A. Giuliano, J. Palefsky, 2011, The New England journal of medicine.

Impact of an HPV6/11/16/18 L1 virus‐like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection

C. Wheeler, M. Lehtinen, S. Garland, 2011, International journal of cancer.

The humoral response to Gardasil over four years as defined by Total IgG and competitive Luminex immunoassay

Daron G Ferris, David Radley, S. Garland, 2011, Human vaccines.

Long-Term Follow-up Observation of the Safety, Immunogenicity, and Effectiveness of Gardasil™ in Adult Women

A. Saah, S. Vuocolo, D. Radley, 2013, PloS one.

Survival following massive amitriptyline overdose: The use of intravenous lipid emulsion therapy and the occurrence of acute respiratory distress

D. Radley, C. Bigham, J. Barragry, 2015, Journal of the Intensive Care Society.

Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches

J. Absalon, K. Koury, K. Jansen, 2022, Human vaccines & immunotherapeutics.

Selection of diverse strains to assess broad coverage of the bivalent FHbp meningococcal B vaccine

John L. Perez, K. Jansen, A. Anderson, 2020, npj Vaccines.

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.

E. Antman, E. Braunwald, C. McCabe, 1999, Circulation.

Development of a Multiplexed HPV L1 Virus‐Like Particle Type‐Specific Immunoglobulin Subclass and Isotyping Assay

M. Esser, E. Barr, D. Radley, 2008 .

Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries

Agust Ingi Agustsson, Maria Hortlund, J. Dillner, 2020, EClinicalMedicine.

A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries

Maria Hortlund, J. Dillner, S. Kjaer, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction.

E. Antman, E. Braunwald, A. Bayés de Luna, 2001, The American journal of cardiology.

Safety, Tolerability, and Immunogenicity of Gardasil Given Concomitantly With Menactra and Adacel

K. Reisinger, S. Block, D. Radley, 2010, Pediatrics.

Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age.

S. Halperin, F. Diaz-Mitoma, D. Radley, 2011, Vaccine.

Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel Staphylococcus aureus 4-Antigen Vaccine (SA4Ag)

A. Gurtman, D. Cooper, R. Frenck, 2019, Open forum infectious diseases.

Design of a long-term follow-up effectiveness, immunogenicity and safety study of women who received the 9-valent human papillomavirus vaccine.

S. Kjaer, A. Saah, M. Nygård, 2017, Contemporary clinical trials.

Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, double-blind, placebo-controlled trial in Chinese males and females.

A. Saah, D. Radley, H. Sings, 2012, Vaccine.

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.

S. Madhi, F. Polack, A. Gurtman, 2023, The New England journal of medicine.

Selection of diverse strains to assess broad coverage of the bivalent FHbp meningococcal B vaccine

John L. Perez, K. Jansen, A. Anderson, 2020, npj Vaccines.

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine

P. Dormitzer, A. Gurtman, K. Swanson, 2021, The Journal of infectious diseases.

Potential for Maternally Administered Vaccine for Infant Group B Streptococcus.

Stephanie A. Jones, S. Madhi, J. Absalon, 2023, The New England journal of medicine.

Pregnancy and Infant Outcomes in the Clinical Trials of a Human Papillomavirus Type 6/11/16/18 Vaccine: A Combined Analysis of Five Randomized Controlled Trials

S. Garland, K. Ault, A. Saah, 2009, Obstetrics and gynecology.

Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial

Michael Y. Wang, A. Gurtman, K. Jansen, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, double-blind, placebo-controlled trial in Chinese males and females.

A. Saah, D. Radley, H. Sings, 2012, Vaccine.